AR and prostate carcinoma: YB-1 may also play an important role in prostate cancer, since studies on prostate cancer cell lines and clinical specimens suggest that it may be implicated in androgen receptor (AR) signalling and resistance to anti-androgenic therapy6, 19, 20.